Our pick · Omega-3 Fish Oil

Nordic Naturals Ultimate Omega

Check priceBuy now →

Omega-3 Fish Oil

EPA and DHA from fish oil have strong cardiovascular and cognitive evidence — but dose, form, and freshness matter more than most labels suggest.

By editorialUpdated 2026-05-252 min read

What it's actually good for

Omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) from fish oil — are among the most-studied supplements in existence. Unlike many supplements where the evidence fizzles under scrutiny, omega-3s have genuine clinical data behind them, particularly for cardiovascular markers and triglyceride reduction.

DHA is a major structural fat in the brain and retina, which is why omega-3s are constantly linked to "brain health" — but there's an important distinction between structural importance and proven cognitive enhancement from supplementation.

What the research says

Cardiovascular health (Grade A). The triglyceride-lowering effect of EPA and DHA is well-established and dose-dependent. A 2020 Cochrane review of 86 RCTs found modest reductions in cardiovascular mortality and events with long-chain omega-3 supplementation. The REDUCE-IT trial, using prescription-strength EPA (4 g/day icosapent ethyl), showed a 25% reduction in cardiovascular events in statin-treated patients with elevated triglycerides. The NIH ODS factsheet summarizes the evidence as strongest for people with existing cardiovascular risk factors.

Brain and cognitive function (Grade B). DHA makes up a significant portion of brain membrane phospholipids, and observational studies consistently associate higher omega-3 intake with better cognitive outcomes. However, RCTs of omega-3 supplementation for cognitive enhancement in healthy adults have produced mixed results. The evidence is stronger for slowing cognitive decline in older adults and in populations with low baseline omega-3 intake.

How much, and which form

For general health, 250-500 mg combined EPA+DHA per day aligns with most guidelines. For triglyceride reduction, clinical doses range from 2-4 g/day of EPA+DHA (under medical supervision). There is no formal RDA, but the American Heart Association recommends fatty fish at least twice per week.

Form matters. The triglyceride (rTG) form absorbs better than the cheaper ethyl ester (EE) form. Read the supplement facts panel for EPA and DHA amounts per serving — not just "fish oil," which includes non-omega-3 fats. Freshness also matters: oxidized (rancid) fish oil is common in low-quality products and may be counterproductive.

Safety & interactions

Fish oil is well-tolerated at normal doses. Higher doses can cause fishy aftertaste, burping, and GI discomfort. The main clinical concern is bleeding risk at doses above 3 g/day EPA+DHA, which matters for people on anticoagulants. Fish oil can also modestly lower blood pressure. This is informational, not medical advice — check with a clinician if you're on blood thinners or managing cardiovascular conditions.

How we picked the brand

An omega-3 product earns a spot when it uses a well-absorbed form (rTG preferred), clearly labels EPA and DHA per serving, passes third-party testing for purity, potency, and oxidation levels (IFOS 5-star / ConsumerLab / USP), and is sustainably sourced. (Specific brand pick pending verification — see frontmatter.)

Claim-by-claim

Each claim graded independently

The overall grade is the floor. Some claims are stronger or weaker than the headline.

A

Reduces cardiovascular risk markers (triglycerides, inflammation)

Strong meta-analytic evidence for triglyceride reduction; prescription-strength EPA (icosapent ethyl) reduced cardiovascular events in REDUCE-IT trial.

B

Supports brain health and cognitive function

DHA is a major structural component of the brain; observational data is strong, but RCT evidence for cognitive enhancement in healthy adults is mixed.

Discussed by

1 expert
Bullish

Considers high-dose EPA+DHA one of the more evidence-backed supplements, emphasizing the importance of measuring omega-3 index.

Expert mentions are a discovery signal, not an input to the evidence grade.

Sources

3 cited
[01]METAOmega-3 fatty acids for the primary and secondary prevention of cardiovascular diseaseAbdelhamid AS, Brown TJ, Brainard JS, et al.. Cochrane Database Syst Rev. 2020
[02]RCTCardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT)Bhatt DL, Steg PG, Miller M, et al.. N Engl J Med. 2019
[03]GOVTOmega-3 Fatty Acids — Fact Sheet for Health ProfessionalsNIH Office of Dietary Supplements. 2023

When the evidence changes, we’ll tell you.

One short email a month. New A-grades, downgraded claims, and reader questions.

Medical disclaimer. The information on this site is provided for educational purposes only and is not intended as medical advice. It does not constitute a diagnosis, treatment plan, or recommendation for any specific health condition. Always consult a qualified healthcare professional before making changes to your supplement regimen, diet, or lifestyle — especially if you are pregnant, nursing, taking medications, or managing a medical condition.

Affiliate disclosure. Some links on this site are affiliate links. If you purchase through them, we may earn a small commission at no extra cost to you. This never influences our editorial assessments — products are graded solely on the evidence.